###begin article-title 0
Bacterial topoisomerase I as a target for discovery of antibacterial compounds
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 300 315 300 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 320 336 320 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 787 796 787 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 801 808 801 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 300 315 <span type="species:ncbi:632">Yersinia pestis</span>
###xml 320 336 <span type="species:ncbi:562">Escherichia coli</span>
###xml 787 796 <span type="species:ncbi:632">Y. pestis</span>
###xml 801 808 <span type="species:ncbi:562">E. coli</span>
Bacterial topoisomerase I is a potential target for discovery of new antibacterial compounds. Mutant topoisomerases identified by SOS induction screening demonstrated that accumulation of the DNA cleavage complex formed by type IA topoisomerases is bactericidal. Characterization of these mutants of Yersinia pestis and Escherichia coli topoisomerase I showed that DNA religation can be inhibited while maintaining DNA cleavage activity by decreasing the binding affinity of Mg(II) ions. This can be accomplished either by mutation of the TOPRIM motif involved directly in Mg(II) binding or by altering the charge distribution of the active site region. Besides being used to elucidate the key elements for the control of the cleavage-religation equilibrium, the SOS-inducing mutants of Y. pestis and E. coli topoisomerase I have also been utilized as models to study the cellular response following the accumulation of bacterial topoisomerase I cleavage complex. Bacterial topoisomerase I is required for preventing hypernegative supercoiling of DNA during transcription. It plays an important role in transcription of stress genes during bacterial stress response. Topoisomerase I targeting poisons may be particularly effective when the bacterial pathogen is responding to host defense, or in the presence of other antibiotics that induce the bacterial stress response.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 483 486 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2 B3 B4">2&#8211;4</xref>
###xml 767 770 767 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5 B6 B7 B8 B9">5&#8211;9</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9 B10 B11">9&#8211;11</xref>
###xml 635 640 <span type="species:ncbi:9606">Human</span>
Topoisomerases catalyze the interconversion of DNA topological isomers via coupling of DNA phosphodiester bond cleavage and religation with the passage of DNA through the break. By maintaining global DNA supercoiling at optimal level and removing local topological barriers, DNA topoisomerases play vital roles in DNA replication, transcription, repair and recombination (1). Topoisomerases are divided into different subfamilies based on their mechanisms and sequence similarities (2-4). Type I topoisomerases cleave and rejoin one strand of DNA while type II topoisomerases cleave and rejoin a double strand of DNA during catalysis. Human topo IB, IIA and bacterial topo IIA enzymes are well utilized clinical targets for anticancer and antibacterial chemotherapy (5-9). These topoisomerase targeting compounds initiate the cell killing process by either stabilizing or increasing the accumulation of the covalent complex formed between the enzyme and cleaved DNA and are called 'topoisomerase poisons' (9-11). Compounds that interact with type IA topoisomerases with high specificity to increase the level of the covalent complex remain to be identified. The emergence of bacterial pathogens resistant to multiple antibacterial drugs in both the hospital and community setting is a serious global public health problem, presenting an urgent need for discovery of new classes of antibacterial compounds. Based on the similarities in the topoisomerase mechanisms, it should be productive to identify small molecules that can act as poisons of bacterial type IA topoisomerases.
###end p 4
###begin title 5
TYPE IA TOPOISOMERASES BACTERIA
###end title 5
###begin p 6
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 206 222 206 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 523 539 523 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 744 775 744 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli, Salmonella typhimurium</italic>
###xml 780 797 780 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shigella flexneri</italic>
###xml 799 804 799 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17 B18 B19 B20">17&#8211;20</xref>
###xml 863 867 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 894 920 894 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 925 944 925 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1084 1091 1084 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1211 1213 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1372 1373 1372 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 206 222 <span type="species:ncbi:562">Escherichia coli</span>
###xml 523 539 <span type="species:ncbi:562">Escherichia coli</span>
###xml 744 751 <span type="species:ncbi:562">E. coli</span>
###xml 753 775 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 780 797 <span type="species:ncbi:623">Shigella flexneri</span>
###xml 894 920 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 925 944 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 1084 1091 <span type="species:ncbi:562">E. coli</span>
There is at least one type IA topoisomerase found in each bacterial genome (12). Topo I is present in all bacteria and is the major activity responsible for removal of excess negative supercoiling (13). In Escherichia coli, the promoters of topo I and gyrase genes are under homeostatic control by DNA supercoiling to maintain the global level of supercoiling (14,15). Topo III is found in only some of the bacterial genomes. In vitro it is much more efficient in catalyzing DNA decatenation reaction than relaxation (13). Escherichia coli topo III has been proposed to play a role in resolving RecQ associated recombination intermediates (16). Transposon insertion or deletion mutants in the topA gene coding for topo I could be isolated from E. coli, Salmonella typhimurium and Shigella flexneri (17-20). Attempts to isolate transposon insertion mutants in the topA gene were unsuccessful in Mycobacterium tuberculosis and Helicobacter pylori (21,22) suggesting that topo I might be essential in these bacteria. This should be further investigated by additional genetic studies. In E. coli, topo III is also not essential but absence of both type IA topoisomerases resulted in chromosomal segregation defect (23). It was proposed that a type IA topoisomerase activity is required in general for resolving recombination intermediates involving single strand DNA passage (1). A broad spectrum type IA topoisomerase poison that can act on both topo I and topo III would have a target always present in any bacteria.
###end p 6
###begin p 7
###xml 12 24 12 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli topA</italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 12 19 <span type="species:ncbi:562">E. coli</span>
###xml 526 533 <span type="species:ncbi:562">E. coli</span>
Even though E. coli topA mutants are viable, growth at low temperature requires topo I function (24,25). During transcription, the movement of the RNA polymerase complex generates positive supercoils in the DNA template ahead of it and negative supercoils behind it (26). Topo I activity is needed for removal of the negative supercoils to prevent hypernegative supercoiling and R-loop formation (27,28). The importance of topo I function in transcription is also illustrated by the direct protein-protein interaction between E. coli topo I and RNA polymerase (29,30).
###end p 7
###begin title 8
FUNCTION OF BACTERIAL TOPOISOMERASE I IN STRESS RESPONSE AND PATHOGENESIS
###end title 8
###begin p 9
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 235 247 235 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli topA</italic>
###xml 347 349 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 350 352 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 396 400 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 475 477 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 547 554 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 606 611 590 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37 B38">35&#8211;38</xref>
###xml 733 737 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 866 870 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 1017 1026 997 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H. pylori</italic>
###xml 1032 1036 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 1104 1106 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1136 1143 1116 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1195 1199 1175 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gadA</italic>
###xml 1204 1209 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gadBC</italic>
###xml 1267 1269 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1440 1442 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1594 1596 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1597 1599 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 235 242 <span type="species:ncbi:562">E. coli</span>
###xml 547 554 <span type="species:ncbi:562">E. coli</span>
###xml 1017 1026 <span type="species:ncbi:210">H. pylori</span>
###xml 1136 1143 <span type="species:ncbi:562">E. coli</span>
The role of topo I in relaxation of transcription-induced negative supercoiling is probably especially important during stress response when a large number of stress genes have to be induced rapidly for survival (31). Transcription of E. coli topA gene is under control of multiple promoters recognized by sigma32, sigma38 in addition to sigma70 (32,33). Besides these alternative sigma factors, topA transcription is also regulated by binding of Fis to the promoter region (34). Topo I function and regulation have been shown to be important for E. coli response to high temperature and oxidative stress (35-38). RNase H overproduction can partially restore the sigma32-dependent stress genes transcription defect in the absence of topA, indicating that R-loop formation from hypernegative supercoiling at heat shock genes loci is responsible for the effect of the topA mutation. The response to high temperature and oxidative stress is an important element of bacterial pathogen adaptation against host defense. In H. pylori, the topA gene has been shown to be up-regulated by prolonged acid exposure (39). Loss of topo I function in E. coli affects transcription of the acid resistance genes gadA and gadBC involving a mechanism independent of R-loop suppression (40). It was shown recently that a pathway of sigma38 stress response involves unwrapping of the poised inactive transcription complex by DNA relaxation to allow activation (41). The relaxing activity of topo I may play a role via this mechanism in the activation of some of the promoters that are stimulated by DNA relaxation (42,43). The important role of topo I in bacterial stress response and pathogenesis implies that if topo I activity is reduced as a defensive adaptation for an antibiotic acting as type IA topoisomerase poison, the ability of the pathogen to survive in the host environment may be compromised.
###end p 9
###begin p 10
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fooB</italic>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 229 240 229 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. flexneri</italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">invA</italic>
###xml 264 278 264 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 358 372 358 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 518 541 518 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia enterocolitica</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 165 172 <span type="species:ncbi:562">E. coli</span>
###xml 229 240 <span type="species:ncbi:623">S. flexneri</span>
###xml 264 278 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 358 372 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 518 541 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 651 658 <span type="species:ncbi:562">E. coli</span>
Bacterial genes related to pathogenesis and virulence have been shown to be sensitive to topA mutation. These include the fooB gene for fimbriae F1651 in pathogenic E. coli 4787 (44) and the thermally regulated invasive genes of S. flexneri (20). The invA gene of S. typhimurium was poorly expressed in a topA mutant, and this correlated with the ability of S. typhimurium to penetrate tissue culture cells (45). Signature-tagged transposon mutagenesis has identified topA to be one of the genes affecting survival of Yersinia enterocolitica in animal host (46). In addition, topA gene was among those found to be highly expressed by avian pathogenic E. coli (APEC) in infected tissues (47).
###end p 10
###begin p 11
###xml 218 223 218 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48 B49 B50">48&#8211;50</xref>
The lethal mechanism of many bactericidal antibiotics based on different mechanisms of action, including quinolones and ampicillin, have been shown to involve at least in part the formation of reactive oxygen species (48-50). Since bacteria in general would respond to such antibacterial antibiotics with transcription of stress regulons, topo I is expected to interact extensively with negatively supercoiled DNA at the induced transcription loci, and provide additional opportunity for the topo I cleavage complex to be trapped by an inhibitor. Topo I inhibitors that act as poisons may therefore be particularly effective in combination therapy with other antibiotics.
###end p 11
###begin title 12
CELL KILLING BY BACTERIAL TOPOISOMERASE I MUTANTS THAT ACCUMULATE THE COVALENT CLEAVAGE COMPLEX
###end title 12
###begin p 13
###xml 477 484 477 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 833 848 833 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Yersinia pestis</italic>
###xml 869 876 869 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1004 1013 1004 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 1218 1225 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1242 1247 1242 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dinD1</italic>
###xml 1249 1253 1249 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 1374 1378 1371 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dinD</italic>
###xml 1448 1457 1445 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 1736 1738 1721 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1898 1900 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 2055 2057 2040 2042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 2446 2455 2431 2440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 2655 2657 2640 2642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 2732 2734 2717 2719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 477 484 <span type="species:ncbi:562">E. coli</span>
###xml 833 848 <span type="species:ncbi:632">Yersinia pestis</span>
###xml 869 876 <span type="species:ncbi:562">E. coli</span>
###xml 1004 1013 <span type="species:ncbi:632">Y. pestis</span>
###xml 1218 1225 <span type="species:ncbi:562">E. coli</span>
###xml 1448 1457 <span type="species:ncbi:632">Y. pestis</span>
###xml 2446 2455 <span type="species:ncbi:632">Y. pestis</span>
Since molecules that can act effectively as bacterial topo I poisons have not been previously identified, it is important to demonstrate that trapping of topo I cleavage complexes on single-stranded DNA will indeed lead to bacterial cell death, just as tapping of type IIA topoisomerases on double-stranded DNA would. This would validate the targeting of bacterial topo I in the search for novel antibacterial compounds. It is known from previous work that the SOS response of E. coli is induced by the trapping of gyrase cleavage complex by quinolones (51). Topo I mutations that mimic the action of a topoisomerase poison and result in increased accumulation of the cleavage complex may be expected to also induce the SOS response. The isolation of such topo I mutants was achieved by screening for SOS-inducing recombinant mutant Yersinia pestis topo I expressed in E. coli under the control of the tightly-regulated BAD promoter (52). A pool of mutagenized plasmid pYTOP expressing random mutants of Y. pestis topo I was first isolated in the presence of 2% glucose to suppress the expression of any potentially lethal mutant that accumulate the cleavage complex. The mutagenized plasmid was then transformed into E. coli JD5 strain with dinD1::lacZ fusion. Induction of the DNA damage SOS response would result in synthesis of beta-galactosidase from activation of the dinD1 promoter and formation of blue colonies on Xgal plate. SOS-inducing Y. pestis topo I mutants were identified in such blue colonies in the presence of low concentration of arabinose to activate the BAD promoter. Induction of an SOS-inducing mutant topo I with high concentration of arabinose resulted in approximately4 logs loss of viable counts after 2 h (52). The mutation responsible for this phenotype was identified to be a Gly to Ser substitution in the TOPRIM motif DxDxxG conserved in nucleotidyl transferases (53). Mutant topoisomerase with this Gly to Ser substitution was found to be defective in DNA rejoining after formation of the covalent DNA cleavage complex (52). This result demonstrated that accumulation of the covalent cleavage complex of bacterial topo I could indeed lead to rapid bacterial cell death and validated bacterial type IA topoisomerases as useful targets for discovery of novel bactericidal compounds. The Gly to Ser mutation was the only substitution found at that position to have the SOS-inducing and cell killing phenotypes for Y. pestis topo I. The other more bulky substitutions eliminated DNA cleavage activity. A Met to Val substitution immediately following the active site tyrosine was present in the original SOS inducing mutant (52) and was found to enhance DNA cleavage without inhibiting DNA religation (54).
###end p 13
###begin p 14
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 140 147 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 466 468 466 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 794 796 794 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1142 1144 1142 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1310 1312 1310 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1632 1638 1632 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1668 1677 1668 1677 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1724 1731 1724 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1956 1958 1956 1958 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1677 1986 1677 1986 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">Structure of the 67 kDa N-terminal fragment of <italic>E. coli</italic> topo I (PDB ECL1) and the close-up view of the active site showing the nucleophilic tyrosine Y319 and the residues in the TOPRIM motif and active site region where mutations can result in cell killing due to inhibition of Mg<sup>2+</sup> binding and DNA religation.</p>
###xml 1677 1986 1677 1986 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="15">Structure of the 67 kDa N-terminal fragment of <italic>E. coli</italic> topo I (PDB ECL1) and the close-up view of the active site showing the nucleophilic tyrosine Y319 and the residues in the TOPRIM motif and active site region where mutations can result in cell killing due to inhibition of Mg<sup>2+</sup> binding and DNA religation.</p></caption>
###xml 1986 1986 1986 1986 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn936f1"/>
###xml 1668 1986 1668 1986 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="15">Structure of the 67 kDa N-terminal fragment of <italic>E. coli</italic> topo I (PDB ECL1) and the close-up view of the active site showing the nucleophilic tyrosine Y319 and the residues in the TOPRIM motif and active site region where mutations can result in cell killing due to inhibition of Mg<sup>2+</sup> binding and DNA religation.</p></caption><graphic xlink:href="gkn936f1"/></fig>
###xml 140 147 <span type="species:ncbi:562">E. coli</span>
###xml 1724 1731 <span type="species:ncbi:562">E. coli</span>
Mg2+ ions are required for DNA rejoining and DNA relaxation by type IA topoisomerases (13,55). The aspartates in the TOPRIM motif DxDxxG in E. coli topo I have been shown to coordinate two Mg2+ ions (56). Mg2+ binding by the TOPRIM motif is found to be critical for the DNA cleavage-religation equilibrium of bacterial topo I. Characterization of the SOS-inducing and cell killing topo I mutants demonstrated that there are at least three mechanisms of decreasing Mg2+ binding affinity and inhibiting DNA religation (Figure 1). The Gly to Ser mutation at the TOPRIM motif probably distorted the structure of the TOPRIM domain as the first mechanism of perturbing DNA cleavage-religation. Replacement of the conserved Met adjacent to the active site tyrosine with Arg also resulted in reduced Mg2+ binding, inhibition of DNA religation and the cell killing phenotype. Molecular modeling was in agreement with increased positive charge in the active site region due to the substitution of the neutral Met with the positively charged Arg (57). The change in electrostatic potential in the active site provided a second mechanism of perturbing Mg2+ binding and DNA cleavage-religation. It is also expected that interfering with the metal-ligand interaction directly would provide a third mechanism of perturbing Mg2+ binding and DNA cleavage-religation. Results from our recent experiments showed that an Asn substitution at the first TOPRIM motif Asp residue gave rise to an extremely toxic topo I mutant, and the Asn substitution at the second TOPRIM motif Asp residue also resulted in a mutant that was lethal when induced (B. Cheng et al., manuscript in preparation). Figure 1.Structure of the 67 kDa N-terminal fragment of E. coli topo I (PDB ECL1) and the close-up view of the active site showing the nucleophilic tyrosine Y319 and the residues in the TOPRIM motif and active site region where mutations can result in cell killing due to inhibition of Mg2+ binding and DNA religation.
###end p 14
###begin p 15
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 47 54 <span type="species:ncbi:562">E. coli</span>
Structure of the 67 kDa N-terminal fragment of E. coli topo I (PDB ECL1) and the close-up view of the active site showing the nucleophilic tyrosine Y319 and the residues in the TOPRIM motif and active site region where mutations can result in cell killing due to inhibition of Mg2+ binding and DNA religation.
###end p 15
###begin p 16
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 142 144 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 629 634 629 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60 B61 B62">60&#8211;62</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 375 380 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 695 700 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
While the involvement of Mg2+ ions is widely found in many cellular catalytic mechanisms, there is precedence for small molecules affecting Mg2+ interactions being identified as specific inhibitors of a cellular process which have been approved in human therapy. HIV-1 integrase is an important new target for anti-viral therapy for cases resistant to existing drugs against HIV-1 reverse transcrptase and protease (58,59). The integrase mechanism is similar to the type IA topoisomerase mechanism in the use of two aspartates and one glutamate (56) to coordinate two divalent ions and bring about protein conformational change (60-62). Small molecules that can chelate the divalent ions in the HIV-1 integrase active site have been identified and one, raltegravir has been approved for treatment of AIDS patients (63,64). Therefore it is not unreasonable to expect that it may be possible to inhibit the interaction between bacterial topo I and metal ions in the active site with a small molecule and achieve accumulation of the DNA cleavage complex for antibacterial therapy.
###end p 16
###begin p 17
###xml 81 89 81 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 489 497 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
While the TOPRIM motif and surrounding residues around the active site tyrosine (Figure 1) have been identified to be important for controlling DNA cleavage/religation, other regions of the bacterial topo I protein could also affect the level of accumulation of the covalent cleavage complex. Subdomain III with the 5'phosphate of the cleaved DNA bound covalently to the active site tyrosine needs to separate from subdomains I and IV as the enzyme transitioned from the closed structure (Figure 1) to a more open structure during the catalytic cycle for DNA strand passage to take place. Subdomain I then must move back to near its original position before DNA religation can occur. Mutations or small molecules that can stabilize the intermediate complex with subdomain III separated from subdomains I and IV by affecting the protein conformational changes could also lead to increased accumulation of the cleavage complex in vivo and result in cell killing. It is hopeful that further characterization of the SOS-inducing topo I mutants would identify regions in the topo I structure that may be potential binding sites for such small molecules.
###end p 17
###begin title 18
CELLULAR RESPONSE TO TOPOISOMERASE I CLEAVAGE COMPLEX AND THE CELL DEATH PATHWAY
###end title 18
###begin p 19
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 490 497 490 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1208 1210 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 1269 1273 1269 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">recF</italic>
###xml 1278 1282 1278 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">recR</italic>
###xml 1408 1410 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 166 173 <span type="species:ncbi:562">E. coli</span>
###xml 490 497 <span type="species:ncbi:562">E. coli</span>
###xml 851 858 <span type="species:ncbi:562">E. coli</span>
The bacterial topo I mutants that accumulate the cleavage complexes were utilized to study the cellular response to topo I cleavage complex and the repair pathway in E. coli. The homologous recombination function of RecA was found to be required for repair of topo I cleavage complex. Induction of the SOS response by the recombination deficient RecA718 protein was found to be insufficient for repair of topo I mediated DNA cleavage (65) Quinolones are known to induce the SOS response of E. coli via the RecBCD pathway (66). Double-strand DNA breaks and chromosomal fragmentation occur after trapping of the cleavage complex between the gyrase A subunits and both strands of DNA (67,68). Although topo I cleaves only a single-strand of DNA at a time, RecBCD function was also found to be required for induction of the SOS response by RecA (65). The E. coli RecBCD complex unwinds and degrades DNA at double strand breaks with free DNA ends until the RecBCD activity is modified by encountering a Chi site on DNA. The Chi-modified RecBCD nuclease activity generates a 3' single-stranded overhang and facilitates the assembly of a RecA filament on this single-stranded DNA region downstream of the Chi site (69). Mutations in the single-strand gap repair pathway genes recF and recR were found to have no effect on SOS induction or viable colony counts following accumulation of the topo I cleavage complex (65). It remains to be determined how the single strand break covalently linked to topo I protein is converted to a double strand break with free ends that can be processed by the RecBCD complex.
###end p 19
###begin p 20
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
The quinolone induced gyrase cleavage complex blocks DNA replication, but ongoing DNA replication is not necessary or sufficient for the lethal effect of the quinolones (11,70). Depending on the structure of the quinolone, inhibition of protein synthesis following quinolone addition by chloramphenicol may or may not offer protection. This suggests that there is more than one pathway involved for the lethal action of quinolones (11). It is possible that a newly synthesized protein may be required for one of the cell killing pathways. In eukaryotes, Tyr-DNA phosphodiesterase (Tdp1) activity has been shown to cleave the linkage between 3' DNA phosphate and type IB topoisomerases (71,72), and may in addition also be involved in the processing of the type IIA topoisomerases linked to the 5' DNA phosphate (73,74). Homologues of Tdp1 have not been identified in bacterial genomes so it is not known if a bacterial Tyr-DNA phosphodiesterase is available to cleave the linkage between the type IA and type IIA topoisomerase proteins and the 5' phosphates of the cleaved bacterial DNA.
###end p 20
###begin title 21
INHIBITORS OF BACTERIAL TOPOISOEMRASE I
###end title 21
###begin p 22
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 62 69 <span type="species:ncbi:562">E. coli</span>
###xml 208 215 <span type="species:ncbi:562">E. coli</span>
###xml 316 323 <span type="species:ncbi:562">E. coli</span>
###xml 354 361 <span type="species:ncbi:562">E. coli</span>
###xml 439 443 <span type="species:ncbi:9913">calf</span>
Even though DNA gyrase is the primary target of quinolones in E. coli, certain quinolones including perfloxacin, ciprofloxacin, norfloxacin and ofloxacin have been shown to inhibit the relaxation activity of E. coli topo I at concentrations 10-fold or higher of that required to inhibit the supercoiling activity of E. coli gyrase (75,76). Nevertheless, E. coli topo I was found to be significantly more sensitive to these quinolones than calf thymus topoisomerase I and II.
###end p 22
###begin p 23
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topA</italic>
###xml 388 395 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 452 459 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 472 481 472 481 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 545 552 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 562 563 562 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 584 585 584 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 481 653 481 653 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="24">Structures of compounds shown to inhibit relaxation activity of <italic>E. coli</italic> topo I. (<bold>A</bold>) cardiolipin (<xref ref-type="bibr" rid="B77">77</xref>). (<bold>B</bold>) Small molecule leads identified by high-throughput screening (<xref ref-type="bibr" rid="B81">81</xref>).</p>
###xml 481 653 481 653 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="24">Structures of compounds shown to inhibit relaxation activity of <italic>E. coli</italic> topo I. (<bold>A</bold>) cardiolipin (<xref ref-type="bibr" rid="B77">77</xref>). (<bold>B</bold>) Small molecule leads identified by high-throughput screening (<xref ref-type="bibr" rid="B81">81</xref>).</p></caption>
###xml 653 653 653 653 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn936f2"/>
###xml 472 653 472 653 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="24">Structures of compounds shown to inhibit relaxation activity of <italic>E. coli</italic> topo I. (<bold>A</bold>) cardiolipin (<xref ref-type="bibr" rid="B77">77</xref>). (<bold>B</bold>) Small molecule leads identified by high-throughput screening (<xref ref-type="bibr" rid="B81">81</xref>).</p></caption><graphic xlink:href="gkn936f2"/></fig>
###xml 14 21 <span type="species:ncbi:562">E. coli</span>
###xml 205 212 <span type="species:ncbi:562">E. coli</span>
###xml 416 423 <span type="species:ncbi:562">E. coli</span>
###xml 452 459 <span type="species:ncbi:562">E. coli</span>
###xml 545 552 <span type="species:ncbi:562">E. coli</span>
Inhibition of E. coli topo I by phospholipids has also been reported (77). The inhibition of the in vitro relaxation activity by cardiolipin (Figure 2A) could be suppressed by chlorpromazine. Treatment of E. coli cells with chlorpromazine resulted in relaxation of plasmid DNA that was dependent on the function of the topA gene. This suggested that chlorpromazine may interfere with the in vivo interaction between E. coli topo I and phospholipids in E. coli cells (77). Figure 2.Structures of compounds shown to inhibit relaxation activity of E. coli topo I. (A) cardiolipin (77). (B) Small molecule leads identified by high-throughput screening (81).
###end p 23
###begin p 24
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 64 71 <span type="species:ncbi:562">E. coli</span>
Structures of compounds shown to inhibit relaxation activity of E. coli topo I. (A) cardiolipin (77). (B) Small molecule leads identified by high-throughput screening (81).
###end p 24
###begin p 25
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
###xml 73 80 <span type="species:ncbi:562">E. coli</span>
Escherichia coli Tn5 transposase protein has been shown to copurify with E. coli topo I and inhibit its relaxation activity (78). The titration of topo I activity by overexpressed Tn5 transposase leads to filamentation, aberrant nucleoid segregation and cell death (79). The lethality from overexpression of Tn5 transposase could be suppressed by chromosomal mutations that increased the level of topo I protein (80). The N-terminal amino acids of Tn5 transposase are required for the interaction with topo I and the resulting lethal effect from Tn5 transposase overexpression (78,79).
###end p 25
###begin p 26
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 215 224 215 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y. pestis</italic>
###xml 241 256 241 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dinD1::luxCADBE</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 767 784 767 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus subtilis</italic>
###xml 793 800 793 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
###xml 1605 1612 1605 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1638 1646 1638 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 135 142 <span type="species:ncbi:562">E. coli</span>
###xml 215 224 <span type="species:ncbi:632">Y. pestis</span>
###xml 767 784 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 793 800 <span type="species:ncbi:562">E. coli</span>
###xml 1283 1288 <span type="species:ncbi:9606">human</span>
###xml 1325 1330 <span type="species:ncbi:9606">human</span>
###xml 1605 1612 <span type="species:ncbi:562">E. coli</span>
###xml 1625 1630 <span type="species:ncbi:9606">human</span>
In order to identify small molecules as leads for bacterial topo I poisons, a cell based high-throughput assay was developed utilizing E. coli cells with enhanced permeability to small molecules, and overexpressing Y. pestis topo I with the dinD1::luxCADBE luciferase fusion as reporter (81). The goal was to identify small molecules that could induce higher level of SOS response when wild-type recombinant topo I was overexpressed as compared to the recombinant topo I with the active site nucleophile tyrosine residue substituted with alanine. Three small molecules (Figure 2B) capable of enhancing bacterial topo I DNA cleavage and inhibiting the relaxation activity have been identified (81). These compounds had antibacterial activity against the gram positive Bacillus subtilis but not E. coli cells with normal permeability, and may not have the desired specificity against bacterial topo I (81). Compound 1 is the natural product stephenanthrine, a phenanthrene alkaloid. It has structural similarities to benzo[c]phenanthridines and protoberberine alkaloids that have been shown to enhance the DNA cleavage of mammalian topoisomerase I and II (82). Minor groove binders including the bisbenzimide Hoechst 33342 are known to exhibit anti-tumor activity due to inhibition of human topoisomerase I and trapping of the human topoisomerase I cleavage complex (83). More recently, modification of Hoechst 33342 has provided novel ligands that could clear bacterial infections from mammalian cell culture without apparent cytotoxicity to the mammalian cells, and these ligands preferentially inhibited E. coli topo I over human topo I in vitro (Vibha Tandon, personal communications). These results suggest that modification of ligand structures can potentially shift their specificity from inhibiting mammalian topoisomerase I towards targeting bacterial topo I, improving their antimicrobial potential while limiting the cytotoxicity.
###end p 26
###begin title 27
FUTURE DIRECTIONS
###end title 27
###begin p 28
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B84">84</xref>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 314 321 <span type="species:ncbi:562">E. coli</span>
Additional screenings should be carried out to identify compounds that can act as topo I poisons so that they can be developed into leads for new antibacterial therapy. Two high-throughput assays have been developed assaying DNA supercoiling by DNA gyrase and DNA relaxation by eukaryotic topo I and II as well as E. coli topo IV (84). These assays should be applicable to identifying small molecules that can inhibit relaxation by bacterial topo I. Some of the relaxation inhibitors may act by inhibiting DNA religation and be useful as a bacterial topo I poison. Other in vitro high-throughput assays that can directly measure the level of the topo I cleavage complex would be extremely useful for identifying new leads.
###end p 28
###begin p 29
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B85">85</xref>
With sites in bacterial topo I structure important for the control of the DNA cleavage-religation equilibrium being located by the SOS-inducing mutations, it should be possible to identify small molecules that can interact with these sites in the enzyme. The virtual screening approach has been used to discover novel gyrase inhibitors (85), and should be attempted for identifying leads for discovery of bacterial topo I poisons.
###end p 29
###begin title 30
FUNDING
###end title 30
###begin p 31
###xml 0 29 0 29 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 31 39 31 39 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01-GM54</grant-num>
###xml 39 42 39 42 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">226</grant-num>
###xml 44 54 44 54 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01-AI6933</grant-num>
National Institutes of Health (R01-GM54226, R01-AI6933). Funding for open access charge: R01-AI69313.
###end p 31
###begin p 32
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. none declared.
###end p 32
###begin title 33
ACKNOWLEDGEMENTS
###end title 33
###begin p 34
I thank Dr. Bernard I. Weinstein for comments on the manuscript.
###end p 34
###begin title 35
REFERENCES
###end title 35
###begin article-title 36
Cellular roles of DNA topoisomerases: a molecular perspective
###end article-title 36
###begin article-title 37
DNA topoisomerases: structure, function, and mechanism
###end article-title 37
###begin article-title 38
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases
###end article-title 38
###begin article-title 39
DNA topoisomerases: Harnessing and constraining energy to govern chromosome topology
###end article-title 39
###begin article-title 40
Topoisomerase I inhibitors: camptothecins and beyond
###end article-title 40
###begin article-title 41
DNA gyrase as a drug target
###end article-title 41
###begin article-title 42
Topoisomerase enzymes as therapeutic targets for cancer chemotherapy
###end article-title 42
###begin article-title 43
Fluoroquinolones: action and resistance
###end article-title 43
###begin article-title 44
DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage
###end article-title 44
###begin article-title 45
DNA topoisomerase poisons as antitumor drugs
###end article-title 45
###begin article-title 46
Quinolone-mediated bacterial death
###end article-title 46
###begin article-title 47
Origin and evolution of DNA topoisomerases
###end article-title 47
###begin article-title 48
Type IA topoisomerases: a simple puzzle?
###end article-title 48
###begin article-title 49
###xml 28 35 <span type="species:ncbi:562">E. coli</span>
Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling
###end article-title 49
###begin article-title 50
###xml 18 34 <span type="species:ncbi:562">escherichia coli</span>
Regulation of the escherichia coli DNA topoisomerase I gene by DNA supercoiling
###end article-title 50
###begin article-title 51
A role for topoisomerase III in a recombination pathway alternative to RuvABC
###end article-title 51
###begin article-title 52
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes
###end article-title 52
###begin article-title 53
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes
###end article-title 53
###begin article-title 54
###xml 43 65 <span type="species:ncbi:90371">salmonella typhimurium</span>
The genetic control of DNA supercoiling in salmonella typhimurium
###end article-title 54
###begin article-title 55
###xml 51 68 <span type="species:ncbi:623">shigella flexneri</span>
Isolation and characterization of a topA mutant of shigella flexneri
###end article-title 55
###begin article-title 56
###xml 19 38 <span type="species:ncbi:210">helicobacter pylori</span>
Topoisomerase I of helicobacter pylori: juxtaposition with a flagellin gene (flaB) and functional requirement of a fourth zinc finger motif
###end article-title 56
###begin article-title 57
Genetic requirements for mycobacterial survival during infection
###end article-title 57
###begin article-title 58
###xml 80 96 <span type="species:ncbi:562">escherichia coli</span>
Type I topoisomerase activity is required for proper chromosomal segregation in escherichia coli
###end article-title 58
###begin article-title 59
###xml 13 29 <span type="species:ncbi:562">escherichia coli</span>
Viability of escherichia coli topA mutants lacking DNA topoisomerase I
###end article-title 59
###begin article-title 60
###xml 47 63 <span type="species:ncbi:562">escherichia coli</span>
R-loop-dependent hypernegative supercoiling in escherichia coli topA mutants preferentially occurs at low temperatures and correlates with growth inhibition
###end article-title 60
###begin article-title 61
Supercoiling of the DNA template during transcription
###end article-title 61
###begin article-title 62
Growth inhibition mediated by excess negative supercoiling: The interplay between transcription elongation, R-loop formation and DNA topology
###end article-title 62
###begin article-title 63
###xml 86 102 <span type="species:ncbi:562">escherichia coli</span>
Relaxation of transcription-induced negative supercoiling is an essential function of escherichia coli DNA topoisomerase I
###end article-title 63
###begin article-title 64
###xml 27 43 <span type="species:ncbi:562">escherichia coli</span>
Direct interaction between escherichia coli RNA polymerase and the zinc ribbon domains of DNA topoisomerase I
###end article-title 64
###begin article-title 65
###xml 76 92 <span type="species:ncbi:562">escherichia coli</span>
Interaction network containing conserved and essential protein complexes in escherichia coli
###end article-title 65
###begin article-title 66
Topoisomerase function during bacterial responses to environmental challenge
###end article-title 66
###begin article-title 67
###xml 60 76 <span type="species:ncbi:562">escherichia coli</span>
Identification of a heat shock promoter in the topA gene of escherichia coli
###end article-title 67
###begin article-title 68
###xml 14 30 <span type="species:ncbi:562">escherichia coli</span>
Regulation of escherichia coli topA gene transcription: Involvement of a sigmaS-dependent promoter
###end article-title 68
###begin article-title 69
###xml 27 43 <span type="species:ncbi:562">escherichia coli</span>
Differential regulation of escherichia coli topoisomerase I by fis
###end article-title 69
###begin article-title 70
###xml 70 86 <span type="species:ncbi:562">escherichia coli</span>
Effect of the deletion of the sigma 32-dependent promoter (P1) of the escherichia coli topoisomerase I gene on thermotolerance
###end article-title 70
###begin article-title 71
###xml 95 111 <span type="species:ncbi:562">escherichia coli</span>
Increased thermosensitivity associated with topoisomerase I deletion and promoter mutations in escherichia coli
###end article-title 71
###begin article-title 72
###xml 79 95 <span type="species:ncbi:562">escherichia coli</span>
Increased sensitivity to oxidative challenges associated with topA deletion in escherichia coli
###end article-title 72
###begin article-title 73
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli response to hydrogen peroxide: a role for DNA supercoiling, topoisomerase I and fis
###end article-title 73
###begin article-title 74
###xml 64 83 <span type="species:ncbi:210">helicobacter pylori</span>
Identification of genes regulated by prolonged acid exposure in helicobacter pylori
###end article-title 74
###begin article-title 75
###xml 98 114 <span type="species:ncbi:562">escherichia coli</span>
Loss of topoisomerase I function affects the RpoS-dependent and GAD systems of acid resistance in escherichia coli
###end article-title 75
###begin article-title 76
General stress response signalling: unwrapping transcription complexes by DNA relaxation via the sigma38 C-terminal domain
###end article-title 76
###begin article-title 77
###xml 49 71 <span type="species:ncbi:727">haemophilus influenzae</span>
Gene expression changes triggered by exposure of haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis
###end article-title 77
###begin article-title 78
###xml 72 88 <span type="species:ncbi:562">escherichia coli</span>
Genomic transcriptional response to loss of chromosomal supercoiling in escherichia coli
###end article-title 78
###begin article-title 79
Effects of DNA supercoiling and topoisomerases on the expression of genes coding for F165(1), a P-like fimbriae
###end article-title 79
###begin article-title 80
###xml 14 36 <span type="species:ncbi:90371">salmonella typhimurium</span>
Expression of salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling
###end article-title 80
###begin article-title 81
###xml 18 41 <span type="species:ncbi:630">yersinia enterocolitica</span>
Identification of yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis
###end article-title 81
###begin article-title 82
###xml 97 113 <span type="species:ncbi:562">escherichia coli</span>
Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic escherichia coli strain
###end article-title 82
###begin article-title 83
###xml 78 94 <span type="species:ncbi:562">escherichia coli</span>
Involvement of reactive oxygen species in the action of ciprofloxacin against escherichia coli
###end article-title 83
###begin article-title 84
###xml 71 87 <span type="species:ncbi:562">escherichia coli</span>
Gyrase inhibitors induce an oxidative damage cellular death pathway in escherichia coli
###end article-title 84
###begin article-title 85
A common mechanism of cellular death induced by bactericidal antibiotics
###end article-title 85
###begin article-title 86
Induction of the SOS response by new 4-quinolones
###end article-title 86
###begin article-title 87
Bacterial cell killing mediated by topoisomerase I DNA cleavage activity
###end article-title 87
###begin article-title 88
Toprim-a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins
###end article-title 88
###begin article-title 89
Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM gly to ser mutant of bacterial topoisomerase I
###end article-title 89
###begin article-title 90
Bacterial and archeal type I topoisomerases
###end article-title 90
###begin article-title 91
The acidic triad conserved in type IA DNA topoisomerases is required for binding of mg(II) and subsequent conformational change
###end article-title 91
###begin article-title 92
Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region
###end article-title 92
###begin article-title 93
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial
###end article-title 93
###begin article-title 94
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Integrase inhibitors to treat HIV/AIDS
###end article-title 94
###begin article-title 95
Retroviral DNA integration-mechanism and consequences
###end article-title 95
###begin article-title 96
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural determinants of metal-induced conformational changes in HIV-1 integrase
###end article-title 96
###begin article-title 97
Molecular mechanisms in retrovirus DNA integration
###end article-title 97
###begin article-title 98
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: A phase II randomised controlled trial
###end article-title 98
###begin article-title 99
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Raltegravir with optimized background therapy for resistant HIV-1 infection
###end article-title 99
###begin article-title 100
SOS induction by stabilized topoisomerase IA cleavage complex occurs via the RecBCD pathway
###end article-title 100
###begin article-title 101
###xml 76 92 <span type="species:ncbi:562">escherichia coli</span>
Genetic analysis of the requirements for SOS induction by nalidixic acid in escherichia coli
###end article-title 101
###begin article-title 102
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones
###end article-title 102
###begin article-title 103
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 56 72 <span type="species:ncbi:562">escherichia coli</span>
Norfloxacin-induced DNA gyrase cleavage complexes block escherichia coli replication forks, causing double-stranded breaks in vivo
###end article-title 103
###begin article-title 104
The translocating RecBCD enzyme stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated manner
###end article-title 104
###begin article-title 105
###xml 87 103 <span type="species:ncbi:562">escherichia coli</span>
Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of escherichia coli
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast gene for a tyr-DNA phosphodiesterase that repairs topoisomerase I complexes
###end article-title 106
###begin article-title 107
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1
###end article-title 107
###begin article-title 108
###xml 23 28 <span type="species:ncbi:9606">human</span>
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
###end article-title 108
###begin article-title 109
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage
###end article-title 109
###begin article-title 110
###xml 98 114 <span type="species:ncbi:562">escherichia coli</span>
Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on escherichia coli topoisomerase I
###end article-title 110
###begin article-title 111
Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II
###end article-title 111
###begin article-title 112
###xml 14 30 <span type="species:ncbi:562">escherichia coli</span>
Inhibition of escherichia coli DNA topoisomerase I activity by phospholipids
###end article-title 112
###begin article-title 113
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli DNA topoisomerase I copurifies with Tn5 transposase, and Tn5 transposase inhibits topoisomerase I
###end article-title 113
###begin article-title 114
###xml 41 57 <span type="species:ncbi:562">escherichia coli</span>
###xml 143 150 <span type="species:ncbi:562">E. coli</span>
Overexpression of the Tn5 transposase in escherichia coli results in filamentation, aberrant nucleoid segregation, and cell death: analysis of E. coli and transposase suppressor mutations
###end article-title 114
###begin article-title 115
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli DNA topoisomerase I and suppression of killing by Tn5 transposase overproduction: Topoisomerase I modulates Tn5 transposition
###end article-title 115
###begin article-title 116
Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I
###end article-title 116
###begin article-title 117
Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents
###end article-title 117
###begin article-title 118
DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors
###end article-title 118
###begin article-title 119
High-throughput assays for DNA gyrase and other topoisomerases
###end article-title 119
###begin article-title 120
Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening
###end article-title 120

